How Long Should Cancer Survivors Be Followed by Oncology?

MedicalResearch.com Interview with:

MedicalResearch.com Interview with: Dr. Anil K. Sood M.D. Professor and Vice Chair for Translational Research in the Departments of Gynecologic Oncology and Cancer Biology and co-director of the Center for RNA Interference and Non-Coding RNA MD Anderson Cancer Center

Dr. Sood

Dr. Anil K. Sood M.D.
Professor and Vice Chair for Translational Research in the Departments of Gynecologic Oncology and Cancer Biology and co-director of the Center for RNA Interference and Non-Coding RNA
MD Anderson Cancer Center

MedicalResearch.com: What is the background for this study?

Response: Cancer survivorship care involves coordinating between oncologists, surgeons, and primary care teams, yet there are no consistent or universal guidelines to dictate who will oversee which aspects of care, and when.

MedicalResearch.com: What are the main findings?

Response: Some cancer survivorship populations have a short high-risk period and exceedingly low cancer mortality, suggesting their survivorship care may best be overseen by their primary care physician. The highest-risk populations saw a majority of deaths from their primary cancer, and had high-risk periods longer than five-years, suggesting an extended period of survivorship care management by their oncologist.

MedicalResearch.com: What should clinicians and patients take away from your report?

Response: Many patients may be undergoing excessively long survivorship care with their oncologist, while others may be receiving insufficient periods of oncologist-led survivorship care

MedicalResearch.com: What recommendations do you have for future research as a result of this study?

Response: This study looked at broad, organ-based cancer types. The methods used in this study could be performed to further tailor personalized survivorship care based on cancer and patient-level specifics.

All authors have no pertinent disclosures.

MedicalResearch.com: Thank you for your contribution to the MedicalResearch.com community

Citation:

Dood RL, Zhao Y, Armbruster SD, et al. Defining Survivorship Trajectories Across Patients With Solid TumorsAn Evidence-Based Approach. JAMA Oncol. Published online June 02, 2018. doi:10.1001/jamaoncol.2018.2761

 

Note: Content is Not intended as medical advice. Please consult your health care provider regarding your specific medical condition and questions.